Skip to main content

Dr. Alejandro Alva, M.D.

Psychiatry (Psychiatry Physician)

  • Medicare participating

At a glance

Years since graduation
36
In the NPI registry since
2006
Medicare patients seen, 2024
122

Licensed in California since 1997, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Psychiatry Physician primary
    CA license A062396 (first issued 1997; current)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Psychiatry per capita by county →

Where they work

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
122
Services billed
508
Patients’ average age
63
Most frequent Medicare services, 2023
ServiceTimesPatients
Psychotherapy with evaluation and management visit, 30 minutes23392
Established patient office or other outpatient visit, 30-39 minutes13575
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes10015
Established patient office or other outpatient visit, 40-54 minutes9643
Established patient office or other outpatient visit, 20-29 minutes2415
New patient office or other outpatient visit, 60-74 minutes2020
Administration of psychological or neuropsychological test by technician, first 30 minutes1413

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 23 companies reported 268 payments worth $77,471 in total to this clinician.

By type
Compensation for services other than consulting (speaking, faculty)$46,678
Consulting Fee$16,750
Food and Beverage$7,982
Travel and Lodging$6,056
Education$5.45

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Apr 3, 2025Teva Pharmaceuticals USA, Inc.
Apr 3, 2025
Compensation for services other than consulting (speaking, faculty)
AUSTEDO XR · Central Nervous System
$8,893
Mar 25, 2025Neurocrine Biosciences, Inc.
Mar 25, 2025
Consulting Fee
INGREZZA · Neuropsychiatry
$7,188
Oct 23, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Oct 23, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$4,440
Nov 17, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Nov 17, 2025
Consulting Fee
CAPLYTA · PSYCHIATRY
$4,440
Dec 12, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 12, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$4,440
Dec 12, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 12, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$3,885
Dec 17, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 17, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$3,885
Apr 10, 2025Teva Pharmaceuticals USA, Inc.
Apr 10, 2025
Compensation for services other than consulting (speaking, faculty)
AUSTEDO XR · Central Nervous System
$3,250
Mar 27, 2025Teva Pharmaceuticals USA, Inc.
Mar 27, 2025
Compensation for services other than consulting (speaking, faculty)
AUSTEDO XR · Central Nervous System
$3,250
Sep 26, 2025Alkermes, Inc.
Sep 26, 2025
Compensation for services other than consulting (speaking, faculty)
LYBALVI; LYBALVI; LYBALVI · CNS
$3,060
All 34 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 17, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 17, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$3,885
Dec 17, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 17, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$2,220
Dec 12, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 12, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$4,440
Dec 12, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 12, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$3,885
Dec 12, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 12, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$2,775
Dec 12, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 12, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$2,220
Dec 9, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 9, 2025
Travel and Lodging
CAPLYTA · PSYCHIATRY · travel to HEMET, CA · in-kind
$894
Dec 4, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Dec 4, 2025
Travel and Lodging
CAPLYTA · PSYCHIATRY · travel to MENIFEE, CA · in-kind
$833
Nov 17, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Nov 17, 2025
Consulting Fee
CAPLYTA · PSYCHIATRY
$4,440
Nov 11, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Nov 11, 2025
Travel and Lodging
CAPLYTA · PSYCHIATRY · travel to ONTARIO, CA · in-kind
$992
Oct 23, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Oct 23, 2025
Compensation for services other than consulting (speaking, faculty)
CAPLYTA · PSYCHIATRY
$4,440
Oct 16, 2025Alkermes, Inc.
Oct 16, 2025
Compensation for services other than consulting (speaking, faculty)
LYBALVI; LYBALVI; LYBALVI · CNS
$3,060
Oct 14, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Oct 14, 2025
Travel and Lodging
CAPLYTA · PSYCHIATRY · travel to PASADENA, CA · in-kind
$852
Oct 4, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Oct 4, 2025
Travel and Lodging
CAPLYTA · PSYCHIATRY · travel to CHARLOTTE, NC · in-kind
$1,764
Oct 4, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Oct 4, 2025
Travel and Lodging
CAPLYTA · PSYCHIATRY · travel to CHARLOTTE, NC · in-kind
$275
Oct 4, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Oct 4, 2025
Travel and Lodging
CAPLYTA · PSYCHIATRY · travel to CHARLOTTE, NC · in-kind
$91.67
Oct 4, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Oct 4, 2025
Travel and Lodging
CAPLYTA · PSYCHIATRY · travel to CHARLOTTE, NC · in-kind
$44.30
Oct 1, 2025Teva Pharmaceuticals USA, Inc.
Oct 1, 2025
Compensation for services other than consulting (speaking, faculty)
AUSTEDO XR · Central Nervous System
$1,300
Sep 26, 2025Alkermes, Inc.
Sep 26, 2025
Compensation for services other than consulting (speaking, faculty)
LYBALVI; LYBALVI; LYBALVI · CNS
$3,060
Sep 20, 2025Neurocrine Biosciences, Inc.
Sep 20, 2025
Travel and Lodging
INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind
$9.24
Aug 25, 2025Teva Pharmaceuticals USA, Inc.
Aug 25, 2025
Consulting Fee
AUSTEDO XR · Central Nervous System
$705
Aug 13, 2025Alkermes, Inc.
Aug 13, 2025
Consulting Fee
LYBALVI; LYBALVI; LYBALVI · CNS
$960
Jun 4, 2025Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
Jun 4, 2025
Consulting Fee
CAPLYTA · PSYCHIATRY
$2,498
May 2, 2025Alkermes, Inc.
May 2, 2025
Consulting Fee
LYBALVI; LYBALVI; LYBALVI · CNS
$960
Apr 10, 2025Teva Pharmaceuticals USA, Inc.
Apr 10, 2025
Compensation for services other than consulting (speaking, faculty)
AUSTEDO XR · Central Nervous System
$3,250
Apr 10, 2025Teva Pharmaceuticals USA, Inc.
Apr 10, 2025
Travel and Lodging
AUSTEDO XR · Central Nervous System · travel to Newport Beach, CA
$25.20
Apr 10, 2025Teva Pharmaceuticals USA, Inc.
Apr 10, 2025
Travel and Lodging
AUSTEDO XR · Central Nervous System · travel to Newport Beach, CA
$5.00
Apr 3, 2025Teva Pharmaceuticals USA, Inc.
Apr 3, 2025
Compensation for services other than consulting (speaking, faculty)
AUSTEDO XR · Central Nervous System
$8,893
Mar 27, 2025Teva Pharmaceuticals USA, Inc.
Mar 27, 2025
Compensation for services other than consulting (speaking, faculty)
AUSTEDO XR · Central Nervous System
$3,250
Mar 27, 2025Teva Pharmaceuticals USA, Inc.
Mar 27, 2025
Travel and Lodging
AUSTEDO XR · Central Nervous System · travel to Corona Del Mar, CA
$22.40
Mar 27, 2025Teva Pharmaceuticals USA, Inc.
Mar 27, 2025
Travel and Lodging
AUSTEDO XR · Central Nervous System · travel to Corona Del Mar, CA
$5.00
Mar 25, 2025Neurocrine Biosciences, Inc.
Mar 25, 2025
Consulting Fee
INGREZZA · Neuropsychiatry
$7,188
Mar 1, 2025Neurocrine Biosciences, Inc.
Mar 1, 2025
Travel and Lodging
INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind
$243
Feb 4, 2025Janssen Pharmaceuticals, Inc
Feb 4, 2025
Education
in-kind
$5.45

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $34,391 in research payments for these studies, mostly to the institutions running them.

  • A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT)
    Janssen Research & Development, LLC
  • A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Aticaprant 10 mg and 5 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disord…
    Janssen Research & Development, LLC

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Psychiatry clinicians in Costa Mesa

Sources

NPI registry (CMS NPPES, November 2026; record last updated January 23, 2026), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1801816764. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.